General Motors Introduces AllElectric Cadillac Vistiq With 300Mile Range Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down Potential Impact of Ebola Outbreak on Healthcare and Biotech Investments General Dynamics Stock Faces Mixed Analyst Outlook Amid Defense Sector Volatility Lowes Stock May Be Underestimated Says Jim Cramer Frankfurt Airports New Sky Line Train Faces Technical Disruption Shortly After Launch RMTI Q1 2026 Earnings EPS Miss Drags Stock Down 47 TTRX Q1 2026 Earnings Narrow Loss Slightly Misses Estimates as PreRevenue Biotech Advances Pipeline Skye Bioscience Inc SKYE Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Surges on Pipeline Progress Krystal Biotech KRYS Q1 2026 Earnings Strong Earnings Beat Amidst Modest Stock Decline Netcapital Inc NCPL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment FTRE Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements LiveRamp Holdings RAMP Slight Dip Amid Consolidation Near Resistance Old Republic International ORI Slips 132 as Defensive Sectors Face ProfitTaking WD40 Company WDFC Dips 105 as Shares Approach Key Support Level Vizsla Silver VZLA Edges Lower Testing Key Support at 320 Amidst Silver Sector Uncertainty STAK Inc STAK Declines 455 as Stock Hovers Near Key 10 Support Level Paytms Parent One 97 Communications Sees Rs 964 Crore Block Deal Institutional Investors Step In VREX Q1 2026 Earnings EPS Misses Estimates by 18 Shares Rise Despite Revenue Uncertainty Global Water Resources Inc GWRS Surges 7 Support Holding Resistance in View Cheesecake Factory CAKE Holds Above Key Support Amid Modest Gains Greenfire Resources GFR Rallies 218 as Shares Test Key Resistance at 638 Golar LNG GLNG Slips 23 as Traders Eye Support at 4859 After Resistance Test BRC Group Holdings Senior Notes RILYT Edge Lower as Bond Yields Test Resistance vTv Therapeutics Inc VTVT Slips 3 as Resistance Holds Traders Eye Support Test TriplePoint Venture Growth BDC TPVG Slips 21 as Pressure Mounts Near Key Support BioMarin Pharmaceutical BMRN Holds Steady Near Support as Investors Evaluate Pipeline Progress